AKT1 and breast carcinoma: In addition, our data show that α-TEA not only enhances rapamycin suppression of mTOR and induction of apoptosis, but also suppresses rapamycin-mediated feedback activation of AKT, providing a rationale for developing a combination regimen of mTOR+α-TEA for breast cancer treatment.